Wednesday, 4 August 2021

New study details enzyme that allows coronavirus to resist antiviral medications

New study details enzyme that allows coronavirus to resist antiviral medications
New study details enzyme that allows coronavirus to resist antiviral medications

The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus’s defenses.

admin Wed, 08/04/2021 - 16:16

source https://www.pharmatutor.org/pharma-news/2021/new-study-details-enzyme-that-allows-coronavirus-to-resist-antiviral-medications

No comments:

Post a Comment

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...